Ameriprise Financial Inc. cut its holdings in Teleflex Incorporated (NYSE:TFX) by 4.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 420,311 shares of the medical technology company’s stock after selling 21,748 shares during the quarter. Ameriprise Financial Inc. owned 0.93% of Teleflex worth $101,704,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of the stock. 361 Capital LLC purchased a new stake in shares of Teleflex in the third quarter valued at approximately $744,000. Commonwealth Equity Services Inc boosted its stake in shares of Teleflex by 32.4% in the third quarter. Commonwealth Equity Services Inc now owns 4,699 shares of the medical technology company’s stock valued at $1,137,000 after buying an additional 1,150 shares in the last quarter. Oak Ridge Investments LLC boosted its stake in shares of Teleflex by 14.5% in the third quarter. Oak Ridge Investments LLC now owns 16,406 shares of the medical technology company’s stock valued at $3,970,000 after buying an additional 2,079 shares in the last quarter. Russell Investments Group Ltd. boosted its stake in shares of Teleflex by 20.0% in the third quarter. Russell Investments Group Ltd. now owns 106,239 shares of the medical technology company’s stock valued at $25,706,000 after buying an additional 17,706 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its stake in shares of Teleflex by 1.6% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 128,651 shares of the medical technology company’s stock valued at $31,130,000 after buying an additional 2,050 shares in the last quarter. Hedge funds and other institutional investors own 89.11% of the company’s stock.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $241.88, for a total value of $48,376.00. Following the completion of the transaction, the director now directly owns 8,080 shares in the company, valued at $1,954,390.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold 600 shares of company stock valued at $138,162 over the last quarter. Insiders own 2.39% of the company’s stock.
Teleflex Incorporated (NYSE:TFX) traded up $1.16 during trading on Monday, reaching $267.71. The company had a trading volume of 55,300 shares, compared to its average volume of 260,026. The firm has a market capitalization of $12,060.07, a price-to-earnings ratio of 33.09, a P/E/G ratio of 2.29 and a beta of 1.05. Teleflex Incorporated has a 52-week low of $142.97 and a 52-week high of $269.78. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70.
Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.01 by $0.11. The firm had revenue of $534.70 million during the quarter, compared to analyst estimates of $522.94 million. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. The business’s quarterly revenue was up 17.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.80 earnings per share. equities research analysts forecast that Teleflex Incorporated will post 8.35 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 15th. Investors of record on Wednesday, November 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $1.36 annualized dividend and a yield of 0.51%. Teleflex’s payout ratio is currently 24.82%.
TFX has been the subject of several research reports. Deutsche Bank AG reaffirmed a “buy” rating and set a $238.00 price objective (up from $220.00) on shares of Teleflex in a report on Wednesday, August 9th. Jefferies Group LLC reissued a “buy” rating and issued a $253.00 price target (up from $230.00) on shares of Teleflex in a report on Wednesday, August 9th. Needham & Company LLC reissued a “buy” rating on shares of Teleflex in a report on Friday, August 4th. Zacks Investment Research raised Teleflex from a “hold” rating to a “buy” rating and set a $233.00 price target for the company in a report on Friday, August 25th. Finally, Stephens reissued a “buy” rating and issued a $270.00 price target (up from $230.00) on shares of Teleflex in a report on Monday, September 25th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $274.44.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.